{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T02:36:43Z","timestamp":1793241403270,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T00:00:00Z","timestamp":1593475200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T00:00:00Z","timestamp":1593475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Protein bound uremic toxins, such as <jats:italic>p<\/jats:italic>-cresol, cannot be effectively removed by conventional dialysis techniques and are accumulated in plasma, thus contributing to progression of both chronic kidney disease (CKD) and cardiovascular disease (CVD). Pathological effects of uremic toxins include activation of inflammatory response, endothelial dysfunction and release of endothelial microvesicles. To date, the role of <jats:italic>p<\/jats:italic>-cresol in endothelial microvesicles formation has not been analyzed. The aim of the present study was evaluate the effects of endothelial microvesicles released by <jats:italic>p<\/jats:italic>-cresol (PcEMV) on endothelial dysfunction. An in vitro model of endothelial damage mediated by <jats:italic>p<\/jats:italic>-cresol was proposed to evaluate the functional effect of PcEMV on the endothelial repair process carried out by endothelial cells and microRNA (miRNA) that could be involved in this process. We observed that <jats:italic>p<\/jats:italic>-cresol induced a greater release of microvesicles in endothelial cells. These microvesicles altered regenerative capacity of endothelial cells, decreasing their capacity for cell migration and their potential to form vascular structures in vitro. Moreover, we observed increased cellular senescence and a deregulation of miRNA-146b-5p and miRNA-223-3p expression in endothelial cells treated with endothelial microvesicles released by <jats:italic>p<\/jats:italic>-cresol. In summary our data show that microvesicles generated in endothelial cells treated with <jats:italic>p<\/jats:italic>-cresol (PcEMV) interfere with the endothelial repair process by decreasing the migratory capacity, the ability to form new vessels and increasing the senescence of mature endothelial cells. These alterations could be mediated by the upregulation of miRNA-146b-5p and miRNA-223-3p.<\/jats:p>","DOI":"10.1038\/s41598-020-67574-6","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T10:04:05Z","timestamp":1593511445000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Role of endothelial microvesicles released by p-cresol on endothelial dysfunction"],"prefix":"10.1038","volume":"10","author":[{"given":"Fatima","family":"Guerrero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Carmona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Obrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jose","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagrario","family":"Soriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Antonio","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Mart\u00edn-Malo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Aljama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,30]]},"reference":[{"key":"67574_CR1","doi-asserted-by":"publisher","first-page":"e0158765","DOI":"10.1371\/journal.pone.0158765","volume":"11","author":"NR Hill","year":"2016","unstructured":"Hill, N. R. et al. Global prevalence of chronic kidney disease\u2014a systematic review and meta-analysis. PLoS ONE 11, e0158765 (2016).","journal-title":"PLoS ONE"},{"key":"67574_CR2","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1111\/j.1523-1755.2005.09801.x","volume":"98","author":"A Schieppati","year":"2005","unstructured":"Schieppati, A. & Remuzzi, G. Chronic renal diseases as a public health problem: epidemiology, social, and economic implications. Kidney Int. Suppl. 98, S7\u2013S10 (2005).","journal-title":"Kidney Int. Suppl."},{"key":"67574_CR3","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0140-6736(05)17789-7","volume":"365","author":"A Meguid El Nahas","year":"2005","unstructured":"Meguid El Nahas, A. & Bello, A. K. Chronic kidney disease: the global challenge. Lancet 365, 331\u2013340 (2005).","journal-title":"Lancet"},{"key":"67574_CR4","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0140-6736(13)60595-4","volume":"382","author":"RT Gansevoort","year":"2013","unstructured":"Gansevoort, R. T. et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet 382, 339\u2013352 (2013).","journal-title":"Lancet"},{"key":"67574_CR5","doi-asserted-by":"publisher","first-page":"505","DOI":"10.2215\/CJN.03670807","volume":"3","author":"P Stenvinkel","year":"2008","unstructured":"Stenvinkel, P. et al. Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? Clin. J. Am. Soc. Nephrol. 3, 505\u2013521 (2008).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"67574_CR6","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1525-139X.2009.00594.x","volume":"22","author":"T G\u00fcnthner","year":"2009","unstructured":"G\u00fcnthner, T. et al. Endothelium and vascular smooth muscle cells in the context of uremia. Semin. Dial. 22, 428\u2013432 (2009).","journal-title":"Semin. Dial."},{"key":"67574_CR7","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/j.1523-1755.2004.00399.x","volume":"65","author":"L Dou","year":"2004","unstructured":"Dou, L. et al. The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair. Kidney Int. 65, 442\u2013451 (2004).","journal-title":"Kidney Int."},{"key":"67574_CR8","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1160\/TH03-07-0491","volume":"92","author":"C Cerini","year":"2004","unstructured":"Cerini, C. et al. p-cresol, a uremic retention solute, alters the endothelial barrier function in vitro. Thromb. Haemost. 92, 140\u2013150 (2004).","journal-title":"Thromb. Haemost."},{"key":"67574_CR9","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1053\/j.ajkd.2009.04.022","volume":"54","author":"BK Meijers","year":"2009","unstructured":"Meijers, B. K. et al. The uremic retention solute p-cresyl sulfate and markers of endothelial damage. Am. J. Kidney Dis. 54, 891\u2013901 (2009).","journal-title":"Am. J. Kidney Dis."},{"key":"67574_CR10","doi-asserted-by":"publisher","first-page":"4390","DOI":"10.3390\/toxins7114390","volume":"7","author":"C Gao","year":"2015","unstructured":"Gao, C. et al. Indolic uremic solutes enhance procoagulant activity of red blood cells through phosphatidylserine exposure and microparticle release. Toxins 7, 4390\u20134403 (2015).","journal-title":"Toxins"},{"key":"67574_CR11","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/j.1538-7836.2005.01780.x","volume":"4","author":"V Faure","year":"2006","unstructured":"Faure, V. et al. Elevation of circulating endothelial microparticles in patients with chronic renal failure. J. Thromb. Haemost. 4, 566\u2013573 (2006).","journal-title":"J. Thromb. Haemost."},{"key":"67574_CR12","doi-asserted-by":"publisher","first-page":"3430","DOI":"10.1681\/ASN.2005030310","volume":"16","author":"AW Martinez","year":"2005","unstructured":"Martinez, A. W., Recht, N. S., Hostetter, T. H. & Meyer, T. W. Removal of p-cresol sulfate by hemodialysis. J. Am. Soc. Nephrol. 16, 3430\u20133436 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"67574_CR13","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1038\/ki.2008.31","volume":"73","author":"BK Meijers","year":"2008","unstructured":"Meijers, B. K. et al. Free p-cresol is associated with cardiovascular disease in hemodialysis patients. Kidney Int. 73, 1174\u20131180 (2008).","journal-title":"Kidney Int."},{"key":"67574_CR14","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1038\/sj.ki.5000115","volume":"69","author":"B Bammens","year":"2006","unstructured":"Bammens, B., Evenepoel, P., Keuleers, H., Verbeke, K. & Vanrenterghem, Y. Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients. Kidney Int. 69, 1081\u20131087 (2006).","journal-title":"Kidney Int."},{"key":"67574_CR15","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1038\/labinvest.2010.152","volume":"90","author":"HC Anderson","year":"2010","unstructured":"Anderson, H. C., Mulhall, D. & Garimella, R. Role of extracellular membrane vesicles in the pathogenesis of various diseases, including cancer, renal diseases, atherosclerosis, and arthritis. Lab. Invest. 90, 1549\u20131557 (2010).","journal-title":"Lab. Invest."},{"key":"67574_CR16","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1681\/ASN.2005050535","volume":"16","author":"N Amabile","year":"2005","unstructured":"Amabile, N. et al. Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J. Am. Soc. Nephrol. 16, 3381\u20133388 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"67574_CR17","doi-asserted-by":"publisher","first-page":"666","DOI":"10.3389\/fphys.2017.00666","volume":"8","author":"A Carmona","year":"2017","unstructured":"Carmona, A. et al. Microvesicles derived from indoxyl sulfate treated endothelial cells induce endothelial progenitor cells dysfunction. Front. Physiol. 8, 666 (2017).","journal-title":"Front. Physiol."},{"key":"67574_CR18","doi-asserted-by":"publisher","first-page":"e114446","DOI":"10.1371\/journal.pone.0114446","volume":"9","author":"MC Chang","year":"2014","unstructured":"Chang, M. C. et al. p-Cresol affects reactive oxygen species generation, cell cycle arrest, cytotoxicity and inflammation\/atherosclerosis-related modulators production in endothelial cells and mononuclear cells. PLoS ONE 9, e114446 (2014).","journal-title":"PLoS ONE"},{"key":"67574_CR19","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.2215\/CJN.07971109","volume":"5","author":"BK Meijers","year":"2010","unstructured":"Meijers, B. K. et al. p-Cresol and cardiovascular risk in mild-to-moderate kidney disease. Clin. J. Am. Soc. Nephrol. 5, 1182\u20131189 (2010).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"67574_CR20","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1159\/000350843","volume":"35","author":"T Niwa","year":"2013","unstructured":"Niwa, T. Removal of protein-bound uraemic toxins by haemodialysis. Blood. Purif. 35, 20\u201325 (2013).","journal-title":"Blood. Purif."},{"key":"67574_CR21","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1681\/ASN.2011121175","volume":"23","author":"F Duranton","year":"2012","unstructured":"Duranton, F. et al. Normal and pathologic concentrations of uremic toxins. J. Am. Soc. Nephrol. 23, 1258\u20131270 (2012).","journal-title":"J. Am. Soc. Nephrol."},{"key":"67574_CR22","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3390\/toxins11050267","volume":"11","author":"G Favretto","year":"2019","unstructured":"Favretto, G. et al. Endothelial microparticles in uremia: biomarkers and potential therapeutic targets. Toxins 11, 267 (2019).","journal-title":"Toxins"},{"key":"67574_CR23","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1160\/TH03-07-0487","volume":"91","author":"FL Dignat-George","year":"2004","unstructured":"Dignat-George, F. L. et al. Endothelial microparticles: a potential contribution to the thrombotic complications of the antiphospholipid syndrome. Thromb. Haemost. 91, 667\u2013673 (2004).","journal-title":"Thromb. Haemost."},{"key":"67574_CR24","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1161\/hc4701.100516","volume":"104","author":"CM Boulanger","year":"2001","unstructured":"Boulanger, C. M. et al. Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 104, 2649\u20132652 (2001).","journal-title":"Circulation"},{"key":"67574_CR25","doi-asserted-by":"publisher","first-page":"30","DOI":"10.2215\/CJN.05340610","volume":"6","author":"M Yu","year":"2011","unstructured":"Yu, M., Kim, Y. J. & Kang, D. H. Indoxyl sulfate-induced endothelial dysfunction in patients with chronic kidney disease via an induction of oxidative stress. Clin. J. Am. Soc. Nephrol. 6, 30\u201339 (2011).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"67574_CR26","doi-asserted-by":"publisher","first-page":"778","DOI":"10.18632\/aging.101191","volume":"9","author":"M Alique","year":"2017","unstructured":"Alique, M. et al. Microvesicles from the plasma of elderly subjects and from senescent endothelial cells promote vascular calcification. Aging 9, 778\u2013789 (2017).","journal-title":"Aging"},{"key":"67574_CR27","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1161\/CIRCRESAHA.117.309681","volume":"120","author":"D Todorova","year":"2017","unstructured":"Todorova, D., Simoncini, S., Lacroix, R., Sabatier, F. & Dignat-George, F. Extracellular vesicles in angiogenesis. Circ. Res. 120, 1658\u20131673 (2017).","journal-title":"Circ. Res."},{"key":"67574_CR28","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.jacc.2006.09.050","volume":"49","author":"E Shantsila","year":"2007","unstructured":"Shantsila, E., Watson, T. & Lip, G. Y. Endothelial progenitor cells in cardiovascular disorders. J. Am. Coll. Cardiol. 49, 741\u2013752 (2007).","journal-title":"J. Am. Coll. Cardiol."},{"key":"67574_CR29","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1097\/HJH.0b013e328335d0a8","volume":"28","author":"GN Charon","year":"2010","unstructured":"Charon, G. N. et al. Circulating microparticles may influence early carotid artery remodeling. J. Hypertens. 28, 789\u2013796 (2010).","journal-title":"J. Hypertens."},{"key":"67574_CR30","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3389\/fphys.2015.00395","volume":"6","author":"C Luna","year":"2015","unstructured":"Luna, C., Carmona, A., Alique, M., Carracedo, J. & Ramirez, R. TNF\u03b1-damaged-HUVECs microparticles modify endothelial progenitor cell functional activity. Front. Physiol. 6, 395 (2015).","journal-title":"Front. Physiol."},{"key":"67574_CR31","doi-asserted-by":"publisher","first-page":"F1302","DOI":"10.1152\/ajprenal.00114.2014","volume":"307","author":"S Soriano","year":"2014","unstructured":"Soriano, S. et al. Endothelial damage and vascular calcification in patients with chronic kidney disease. Am. J. Physiol. Renal Physiol. 307, F1302\u2013F1311 (2014).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"67574_CR32","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.kint.2015.11.020","volume":"89","author":"SC Hung","year":"2016","unstructured":"Hung, S. C. et al. Indoxyl sulfate suppresses endothelial progenitor cell-mediated neovascularization. Kidney Int. 89, 574\u2013585 (2016).","journal-title":"Kidney Int."},{"key":"67574_CR33","first-page":"2013","volume":"9","author":"L Li","year":"2017","unstructured":"Li, L., Li, J., Li, X. & Yuan, F. H. Protein-bound p-cresol inhibits human umbilical vein endothelial cell proliferation by inducing cell cycle arrest at G0\/G1. Am. J. Transl. Res. 9, 2013\u20132023 (2017).","journal-title":"Am. J. Transl. Res."},{"key":"67574_CR34","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.devcel.2008.07.002","volume":"15","author":"S Wang","year":"2008","unstructured":"Wang, S. et al. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev. Cell 15, 261\u2013271 (2008).","journal-title":"Dev. Cell"},{"key":"67574_CR35","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1073\/pnas.0707493105","volume":"105","author":"TA Harris","year":"2008","unstructured":"Harris, T. A., Yamakuchi, M., Ferlito, M., Mendell, J. T. & Lowenstein, C. J. MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc. Natl. Acad. Sci. U S A 105, 1516\u20131521 (2008).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"67574_CR36","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/cvr\/cvn156","volume":"79","author":"C Urbich","year":"2008","unstructured":"Urbich, C., Kuehbacher, A. & Dimmeler, S. Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc. Res. 79, 581\u2013588 (2008).","journal-title":"Cardiovasc. Res."},{"key":"67574_CR37","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1007\/s10753-012-9467-0","volume":"35","author":"WD Xu","year":"2012","unstructured":"Xu, W. D., Lu, M. M., Pan, H. F. & Ye, D. Q. Association of MicroRNA-146a with autoimmune diseases. Inflammation 35, 1525\u20131529 (2012).","journal-title":"Inflammation"},{"key":"67574_CR38","doi-asserted-by":"publisher","first-page":"161","DOI":"10.4161\/epi.26931","volume":"9","author":"AM Zawada","year":"2014","unstructured":"Zawada, A. M. et al. Massive analysis of cDNA Ends (MACE) and miRNA expression profiling identifies proatherogenic pathways in chronic kidney disease. Epigenetics 9, 161\u2013172 (2014).","journal-title":"Epigenetics"},{"key":"67574_CR39","doi-asserted-by":"publisher","first-page":"e0179850","DOI":"10.1371\/journal.pone.0179850","volume":"12","author":"D Pfeiffer","year":"2017","unstructured":"Pfeiffer, D., Ro\u00dfmanith, E., Lang, I. & Falkenhagen, D. miR-146a, miR-146b, and miR-155 increase expression of IL-6 and IL-8 and support HSP10 in an in vitro sepsis model. PLoS ONE 12, e0179850 (2017).","journal-title":"PLoS ONE"},{"key":"67574_CR40","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/emmm.201202318","volume":"5","author":"HS Cheng","year":"2013","unstructured":"Cheng, H. S. et al. MicroRNA-146 represses endothelial activation by inhibiting pro-inflammatory pathways. EMBO. Mol. Med. 5, 1017\u20131034 (2013).","journal-title":"EMBO. Mol. Med."},{"key":"67574_CR41","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.atherosclerosis.2011.03.034","volume":"217","author":"M Vasa-Nicotera","year":"2011","unstructured":"Vasa-Nicotera, M. et al. miR-146a is modulated in human endothelial cell with aging. Atherosclerosis 217, 326\u2013330 (2011).","journal-title":"Atherosclerosis"},{"key":"67574_CR42","first-page":"12901","volume":"8","author":"H Wang","year":"2015","unstructured":"Wang, H. et al. miR-146b-5p promotes VSMC proliferation and migration. Int. J. Clin. Exp. Pathol. 8, 12901\u201312907 (2015).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"67574_CR43","doi-asserted-by":"publisher","first-page":"e0181562","DOI":"10.1371\/journal.pone.0181562","volume":"12","author":"TY Chang","year":"2017","unstructured":"Chang, T. Y. et al. Dysregulation of endothelial colony-forming cell function by a negative feedback loop of circulating miR-146a and -146b in cardiovascular disease patients. PLoS ONE 12, e0181562 (2017).","journal-title":"PLoS ONE"},{"key":"67574_CR44","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.bbadis.2013.10.005","volume":"1842","author":"F Ta\u00efbi","year":"2014","unstructured":"Ta\u00efbi, F. et al. Possible involvement of microRNAs in vascular damage in experimental chronic kidney disease. Biochim. Biophys. Acta 1842, 88\u201398 (2014).","journal-title":"Biochim. Biophys. Acta"},{"key":"67574_CR45","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.bbadis.2014.03.005","volume":"1842","author":"F Ta\u00efbi","year":"2014","unstructured":"Ta\u00efbi, F., Metzinger-Le Meuth, V., Massy, Z. A. & Metzinger, L. miR-223: an inflammatory oncomiR enters the cardiovascular field. Biochim. Biophys. Acta 1842, 1001\u20131009 (2014).","journal-title":"Biochim. Biophys. Acta"},{"key":"67574_CR46","doi-asserted-by":"publisher","first-page":"e108468","DOI":"10.1371\/journal.pone.0108468","volume":"9","author":"GH Dai","year":"2014","unstructured":"Dai, G. H. et al. MicroRNA-223-3p inhibits the angiogenesis of ischemic cardiac microvascular endothelial cells via affecting RPS6KB1\/hif-1a signal pathway. PLoS ONE 9, e108468 (2014).","journal-title":"PLoS ONE"},{"key":"67574_CR47","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.bone.2016.11.016","volume":"95","author":"M Ulbing","year":"2017","unstructured":"Ulbing, M. et al. MicroRNAs 223\u20133p and 93\u20135p in patients with chronic kidney disease before and after renal transplantation. Bone 95, 115\u2013123 (2017).","journal-title":"Bone"},{"key":"67574_CR48","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1016\/j.jacc.2015.03.570","volume":"65","author":"Z Shan","year":"2015","unstructured":"Shan, Z. et al. An endocrine genetic signal between blood cells and vascular smooth muscle cells: role of MicroRNA-223 in smooth muscle function and atherogenesis. J. Am. Coll. Cardiol. 65, 2526\u20132537 (2015).","journal-title":"J. Am. Coll. Cardiol."},{"key":"67574_CR49","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.atherosclerosis.2014.09.033","volume":"237","author":"S Li","year":"2014","unstructured":"Li, S. et al. MicroRNA-223 inhibits tissue factor expression in vascular endothelial cells. Atherosclerosis 237, 514\u2013520 (2014).","journal-title":"Atherosclerosis"},{"key":"67574_CR50","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1472-6882-9-45","volume":"9","author":"H Izuta","year":"2009","unstructured":"Izuta, H. et al. Bee products prevent VEGF-induced angiogenesis in human umbilical vein endothelial cells. BMC Complement. Altern. Med. 9, 45 (2009).","journal-title":"BMC Complement. Altern. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-67574-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-67574-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-67574-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T13:12:44Z","timestamp":1670332364000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-67574-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,30]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["67574"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-67574-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,30]]},"assertion":[{"value":"22 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10657"}}